Edition:
United States

Novus Therapeutics Inc (NVUS.OQ)

NVUS.OQ on NASDAQ Stock Exchange Capital Market

6.12USD
3:46pm EDT
Change (% chg)

$-0.31 (-4.82%)
Prev Close
$6.43
Open
$6.39
Day's High
$6.66
Day's Low
$6.00
Volume
7,417
Avg. Vol
9,689
52-wk High
$8.61
52-wk Low
$3.13

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.362
FY 2017 Dec '17 0.00 -0.294
Sep '17 0.00 -0.428
Jun '17 0.00 -1.603
Mar '17 0.00 -0.428
FY 2016 Dec '16 0.00 -1.485
Sep '16 0.00 -3.686
Jun '16 0.00 -5.378
Mar '16 0.00 -4.545
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 1 -0.31 -0.31 -0.31 --
Quarter Ending Sep-18 1 -0.41 -0.41 -0.41 --
Year Ending Dec-18 1 -1.49 -1.49 -1.49 --
Year Ending Dec-19 1 -1.47 -1.47 -1.47 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.97 34.18
P/E High - Last 5 Yrs. -- 41.94 47.65
P/E Low - Last 5 Yrs. -- 23.88 25.16
Beta 0.38 0.79 0.78
Price to Sales (TTM) -- 3.65 8.57
Price to Book (MRQ) 2.49 3.81 4.35
Price to Tangible Book (MRQ) 2.70 4.72 6.03
Price to Cash Flow (TTM) -- 20.36 22.78
% Owned Institutions 51.28 1.27 2.40

Dividends

  Company industry sector
Dividend Yield -- 1.81 1.67
Dividend Yield - 5 Year Avg -- 1.50 1.42
Dividend 5 Year Growth Rate -- -9.55 -6.56
Payout Ratio(TTM) -- 41.65 39.28

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.00 5.00
Sales (TTM) vs TTM 1 Yr. Ago -- 10.42 12.50
Sales - 5 Yr. Growth Rate -- 7.18 7.91
EPS (MRQ) vs Qtr. 1 Yr. Ago 15.33 44.95 40.63
EPS (TTM) vs TTM 1 Yr. Ago 75.52 -- --
EPS - 5 Yr. Growth Rate -- 6.44 8.03
Capital Spending - 5 Yr. Growth Rate -- 6.79 7.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.59 2.56
Current Ratio (MRQ) 14.84 3.68 3.64
LT Debt to Equity (MRQ) 0.00 10.51 12.92
Total Debt to Equity (MRQ) 0.00 14.61 17.37
Interest Coverage (TTM) -- 40.42 35.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.30 54.96
Gross Margin - 5 Yr. Avg. -- 52.75 52.86
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.47 15.70
Operating Margin (TTM) -- 14.39 -0.76
Operating Margin - 5 Yr. Avg. -- 14.19 10.94
Pre-Tax Margin (TTM) -- 14.67 1.32
Pre-Tax Margin - 5 Yr. Avg. -- 14.42 11.12
Net Profit Margin (TTM) -- 11.27 -1.97
Net Profit Margin - 5 Yr. Avg. -- 10.75 7.48
Effective Tax Rate (TTM) -- 21.65 29.90
Effective Tax Rate - 5 Yr. Avg. -- 23.66 24.12

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 847,259,560 736,829,609
Net Income/Employee (TTM) -- 98,722,633 85,814,668
Receivable Turnover (TTM) -- 5.94 6.06
Inventory Turnover (TTM) -- 2.57 3.65
Asset Turnover (TTM) 0.00 0.90 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.23 10.86 10.37
Return on Assets - 5 Yr. Avg. -53.18 11.66 11.09
Return on Investment (TTM) -60.99 13.65 13.17
Return on Investment - 5 Yr. Avg. -57.03 15.12 14.39
Return on Equity (TTM) -61.05 15.43 15.15
Return on Equity - 5 Yr. Avg. -106.86 16.33 15.73
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 81.42 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novus Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 51.42%
# of Holders: 29
Total Shares Held: 4,837,547
3 Mo. Net Change: 865,871
# New Positions: 5
# Closed Positions: 2
# Increased Positions: 10
# Reduced Positions: 9
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.